Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCWC.L Share News (CWC)

  • There is currently no data for CWC

Tuesday broker round-up UPDATE

Tue, 17th Dec 2013 08:14
Advanced Medical Solutions: Panmure Gordon downgrades from buy to hold with a target price of 102p.Antofagasta: Canaccord Genuity cuts target price from 1110p to 1035p, while staying with its buy recommendation.ASOS: Panmure Gordon increases target price from 5950p to 6126p, while downgrading from buy to hold.AstraZeneca: Deutsche Bank raises target price from 3425p to 3600p maintaining a hold recommendation.blur Group: Panmure Gordon ups target price from 677p to 690p and retains a buy recommendation.British American Tabacco: UBS reduces target price from 3850p to 3715p, while its buy recommendation remains unchanged.BTG: Deutsche Bank ups target price from 565p to 610p and reiterates its buy recommendation.Cable & Wireless Communications: Barclays shifts target price from 40p to 43p and retains an equal-weight rating.Daily Mail & General Trust: Westhouse Securities raises target price from 744p to 864p and maintains a neutral rating.Daisy Group: Barclays moves target price from 115p to 130p, but downgrades to underweight.Dixons Retail: Cantor Fitzgerald ups target price from 50p to 60p keeping a buy recommendation. Investec shifts target price from 60p to 62p retaining its buy recommendation.Europa Oil & Gas: Northland lowers target price from 14.3p to 10.1p leaving its buy recommendation unchanged.Experian: Jefferies reduces target price from 1200p to 1090p and keeps a hold recommendation.First Derivates: Panmure Gordon raises target price from 1191p to 1458p and keeps a buy recommendation.First Group: Goldman Sachs shifts target price from 135p to 140p and retains a buy recommendation.GlaxoSmithKline: Deutsche Bank reduces target price from 1800p to 1700p while downgrading to hold.Go-Ahead Group: Goldman Sachs increases target price from 1580p to 2100p and upgrades to a strong buy recommendation.Imagination Technologies: Barclays cuts target price from 250p to 185p and reiterates an equal-weight rating.Informa: Canaccord Genuity cuts target price from 600p to 568p downgrading from buy to hold.Inmarsat: Barclays takes target price from 705p to 740p and keeps an equal-weight rating.KCOM Group: Barclays moves target price from 100p to 115p retaining its overweight rating.Sepura: Westhouse Securities upgrades from add to buy with an unchanged target price of 160p.Stagecoach Group: Goldman Sachs downgrades to sell with a target price of 350p.Trinity Mirror: Panmure Gordon increases target price from 205p to 300p maintaining a buy recommendation.UBM: Deutsche Bank moves target price from 830p to 840p retaining a buy recommendation. Westhouse Securities reduces target price from 812p to 755p, while staying with its buy recommendation. Numis cuts target price from 732p to 710p and maintains a hold recommendation. Barclays reduces target price from 810p to 755p, while staying with its overweight rating.William Hill: Canaccord Genuity lowers target price from 425p to 408p leaving its hold recommendation unaltered.Wood Group: Canaccord Genuity cuts target price from 875p to 825p and reiterates a hold recommendation.Xcite Energy: Cantor Fitzgerald shapes target price from 168p to 167p leaving its buy recommendation unchanged.

Related News

AstraZeneca hails phase 3 trial results of inhibitor Ultomiris
1 hour ago

AstraZeneca hails phase 3 trial results of inhibitor Ultomiris

(Alliance News) - AstraZeneca PLC on Saturday announced new data on its kidney disease treatment Ultomiris.

IN BRIEF: British American Tobacco CEO buys GBP215,300 worth of shares
1 day ago

IN BRIEF: British American Tobacco CEO buys GBP215,300 worth of shares

British American Tobacco PLC - London-based cigarette and nicotine product maker - Chief Executive Tadeu Marroco and person closely associated Luciana...

PRESS: AstraZeneca warns it could delay Europe drug launches - FT
1 day ago

PRESS: AstraZeneca warns it could delay Europe drug launches - FT

(Alliance News) - AstraZeneca PLC could be forced to withhold new medicines from the UK and Europe unless governments pay more for innovative drugs, C...

CWC.L News

Incoming Chairman at Rolls-Royce buys first round of shares
22 Mar 2013

Incoming Chairman at Rolls-Royce buys first round of shares

Ian Davis, the soon-to-be Chairman of Rolls Royce, has purchased his first shares in the company since being appointed to the board at the beginning o...

Wednesday broker round-up UPDATE
20 Feb 2013

Wednesday broker round-up UPDATE

Amara Mining: Goldman Sachs moves target price from 90p to 55p downgrading to neutral. Aureus Mining: Goldman Sachs revises target price from 65p to ...

Tuesday broker round-up UPDATE
19 Feb 2013

Tuesday broker round-up UPDATE

Admiral Group: Investec takes target price from 570p to 582p, but still recommends selling. Advanced Medical Solutions: Investec upgrades from hold t...

London open: Stocks rise after Chinese trade data
8 Feb 2013

London open: Stocks rise after Chinese trade data

Positive data from China helped European stocks rebound on Friday morning, following a sell-off the day before on the back of comments from European C...

C&W Comms incurs further costs to improve efficiency, flexibility
8 Feb 2013

C&W Comms incurs further costs to improve efficiency, flexibility

Telecoms group Cable & Wireless Communications said it is on track to hit its guidance of flat earnings this year, but will take a further 20m dollars...

UPDATE 1-C&W Comms rolls out fibre network after disposals
8 Feb 2013

UPDATE 1-C&W Comms rolls out fibre network after disposals

LONDON, Feb 8 (Reuters) - Cable & Wireless Communications said it had started to roll out a fibre network in its Barbados and Cayman markets as part ...

Wednesday broker round-up - UPDATE
30 Jan 2013

Wednesday broker round-up - UPDATE

Alternative Networks: Investec increases target price from 310p to 330p retaining a buy rating. Anglo American: Deutsche Bank takes price target from...

Friday broker round-up UPDATE
25 Jan 2013

Friday broker round-up UPDATE

Aberdeen Asset Management: Goldman Sachs upgrades to buy with its target price at 360p. APR Energy: JP Morgan lowers target price from 1005p to 950p,...